Cortical hyperintensity on proton density-weighted images: An MR sign of cyclosporine-related encephalopathy

American Journal of Neuroradiology

Volumn 17, Issue 2, 1996, Pages 337-344

  Jansen, Olav ^a,b   Krieger, Derk ^a   Krieger, Silke ^a   Sartor, Klaus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Brain, diseases; Brain, magnetic resonance; Drugs, toxicity

Indexed keywords

CYCLOSPORIN; GADOLINIUM PENTETATE MEGLUMINE; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; MALE; MEDICAL RECORD; NEUROLOGIC EXAMINATION; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; BRAIN DAMAGE, CHRONIC; CEREBRAL CORTEX; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 0030025258     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. De Groen P, Aksamit AJ, Rakela J, Forbes GS, Krom RAF. Central nervous system toxicity after liver transplantation. N Engl J Med 1987;317:861-866
2. De Prada JAV, Martin-Duran R, Garcia-Monco C, et al. Cyclosporine neurotoxicity in heart transplantation. J Heart Transplant 1990;9:581-583
3. Bird GLA, Meadows J, Goka J, Poison R, Williams R. Cyclosporin-associated akinetic mutism and extrapyramidal syndrome after liver transplantation. J Neurol Neurosurg Psychiatry 190;53: 1068-1071
4. Rubin AM, Kang H. Cerebral blindness and encephalopathy with cyclosporin A toxicity. Neurology 1987;37:1072-1076
5. Steg RE, Garcia EG. Complex visual hallucinations and cyclosporine neurotoxicity. Neurology 1991;41:1156-1163
6. McManus RR, O'Hair DP, Schweiger J, Beitzinger J, Siegel R. Cyclosporine-associated central neurotoxicity after heart transplantation. Ann Thorac Surg 1992;53:326-327
7. Lane RJM, Roche SW, Leung AAW, Greco A, Lange LS. Cyclosporin neurotoxicity in cardiac transplant recipients. J Neurol Neurosurg Psychiatry 1988;51:1434-1437
8. Hughes RL. Cyclosporine-related central nervous system toxicity in cardiac transplantation. N Eng J Med 1993;323:420-421
9. Brunberg JA, Kanal E, Hirsch W, van Thiel DH. Chronic acquired hepatic failure: MR imaging of the brain at 1.5 tesla. AJNR Am J Neuroradiol 1991;12:909-914
10. Pujol A, Pijol J, Graus F, et al. Hyperintense globus pallidus on T1-weighted MRI m cirrhotic patients is associated with severity of liver failure. Neurology 1993;43:65-69
11. Berden JHM, Hoitsma AJ, Merx JL, Keyser A. Severe central-nervous-system toxicity associated with cyclosporin. Lancet 1985;1:219-220
12. Estol CJ, Lopez O, Brenner RP, Martinez AJ. Seizures after liver transplantation: a clinicopathologic study. Neurology 1989;39: 1297-1301
13. Takahashi S, Higano S, Ishii K, et al. Hypoc brain damage: cortical laminar necrosis and delayed changes in white matter at sequential MR imaging. Radiology 1993;189:449-456
14. Moreno E, Gomez SR, Gonzalez I, et al. Neurologic complications in liver transplantation. Acta Neurol Scand 1993;87:25-31
15. Sawada H, Udaka F, Seriu M, Shindou M, Kameyama M, Tsujimura M. MRI demonstration of cortical laminar necrosis and delayed white matter injury in anoxic encephalopathy. Neuroradiology 1990;32:319-321
16. Grace AA, Barradas MA, Mikhailidis DP, et al. Cyclosporine A enhances platelet aggregation. Kidney Int 1987;32:889-895
17. Carlesen E, Prydz H. Enhancement of procoagulant activity in stimulated mononuclear blood cells and monocytes by cyclosporine. Transplantation 1987;43:543-548
18. Mihatsch MJ, Thiel G, Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 1988;20:759-771
19. Sloane JP, Lwin KY, BGore ME, Powles RL, Smith JF. Disturbance of blood-brain barrier after bone-marrow transplantation. Lancet 1985;2:280-281
20. Famiglio L, Racusen L, Fivask B, Solez K, Fisher R. Central nervous system toxicity of cyclosporine in a rat model. Transplantation 1989;48:316-321
21. Goldstein GW. The role of brain capillaries in the pathogenesis of hepatic encephalopathy. Hepatology 1984;4:565-567
22. Hauser RA, Zesiewic TA, Roseurgy AS, Martinez C, Olanow CW. Manganese intoxication and chronic liver failure. Ann Neurol 1994;36:871-875
23. Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet 1995; 346:270-274
24. Beveridge T. Pharmacokinetics and metabolism of cyclosporin A. In: White DJG, ed. Cyclosporin A: Proceedings of an International Conference on Cyclosporin A: Cambridge, United Kingdom, Sep 1981. New York: Elsevier, 1982:35-44
25. Maurer G, Loosli HR, Schreier E, Keller B. Disposition of cyclosporine in several animal species and man, I: structural elicidation of its metabolites. Drug Metab Dispos Biol Fate Chem 1984;12: 120-126
26. Lorber MI. Cyclosporine: lessons learned; future strategies. Clin Transplant 1991;5:505-516
27. Vogt D, Ledeman R. Carey W, Broughan T. Neurologic complications of liver transplantation. Transplantation 1988;45:1057-1061